ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,512.80
      0.99%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      -2.20%
      Bitcoin
      67,955.63
      3.29%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Ab Science (AB) Quote

      Ab Science

      Ab Science (AB)

      AllianceBernstein Holding LP
      1.032
      -0.008
      (-0.77%)
      Closed July 26 11:30AM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      1.032
      Bid
      1.028
      Ask
      1.062
      Volume
      18,267
      1.03 Day's Range 1.052
      1.002 52 Week Range 4.465
      Market Cap
      53.737M
      Previous Close
      1.04
      Open
      1.034
      Last Trade
      58
      @
      1.032
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      136,754
      Shares Outstanding
      52,071,069
      Dividend Yield
      -
      PE Ratio
      -4.47
      Earnings Per Share (EPS)
      -0.23
      Revenue
      970k
      Net Profit
      -11.99M

      About Ab Science

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.ab-science.com
      Headquarters
      Paris, Paris, Fra
      Founded
      1970
      Ab Science is listed in the Pharmaceutical Preparations sector of the Euronext with ticker AB. The last closing price for Ab Science was 1.04 €. Over the last year, Ab Science shares have traded in a share price range of 1.002 € to 4.465 €.

      Ab Science currently has 52,071,069 shares outstanding. The market capitalization of Ab Science is 54.15 € million. Ab Science has a price to earnings ratio (PE ratio) of -4.47.

      AB Latest News

      More News

      AB Science annonce des résultats positifs de son étude de Phase 2 évaluant le masitinib dans la Covid-19

      AB Science annonce des résultats positifs de son étude de Phase 2 évaluant le masitinib dans la Covid-19 COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE DES RESULTATS POSITIFS DE SON ETUDE DE PHASE...

      July 08 2024
      GlobeNewswire Inc.

      AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS

      AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL...

      June 28 2024
      GlobeNewswire Inc.

      AB Science - Résultats de l'Assemblée Générale Mixte du 26 juin 2024

      AB Science - Résultats de l'Assemblée Générale Mixte du 26 juin 2024 COMMUNIQUE DE PRESSE RESULTATS DE L’ASSEMBLEE GENERALE MIXTE DU 26 JUIN 2024 Paris, 27 juin 2024, 10h15 Les...

      June 27 2024
      GlobeNewswire Inc.

      AB Science fournit un résumé de la conférence virtuelle qui s'est tenue le 30 mai 2024, faisant le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA

      AB Science fournit un résumé de la conférence virtuelle qui s'est tenue le 30 mai 2024, faisant le point sur la demande d'autorisation de mise sur le marché conditionnelle du...

      May 31 2024
      GlobeNewswire Inc.

      AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA

      AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA COMMUNIQUE DE PRESSE AB SCIENCE FAIT LE POINT SUR LA DEMANDE...

      May 29 2024
      GlobeNewswire Inc.

      AB Science communique un rectificatif sur les comptes consolidés au 31 décembre 2023

      AB Science communique un rectificatif sur les comptes consolidés au 31 décembre 2023          COMMUNIQUE RECTIFICATIF COMMUNIQUE RECTIFICATIF SUR LES COMPTES CONSOLIDES AU 31 DECEMBRE 2023...

      May 17 2024
      GlobeNewswire Inc.

      AB Science annonce ses résultats financiers annuels arrêtés au 31 décembre 2023 et présente un point sur ses activités

      AB Science annonce ses résultats financiers annuels arrêtés au 31 décembre 2023 et présente un point sur ses activités          COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTE SES RÉSULTATS...

      May 15 2024
      GlobeNewswire Inc.

      AB Science annonce la délivrance d’un brevet européen pour le masitinib dans le traitement de la mastocytose sévère avec une protection jusqu’en 2036

      AB Science annonce la délivrance d’un brevet européen pour le masitinib dans le traitement de la mastocytose sévère avec une protection jusqu’en 2036 COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE...

      May 13 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.05-4.621072088721.0821.091.02179801.05273204DE
      4-0.124-10.72664359861.1561.21.016585121.08362178DE
      12-0.868-45.68421052631.92.2951.0021367541.51407453DE
      26-2.778-72.91338582683.8141.0021341492.02857692DE
      52-3.008-74.45544554464.044.4651.0021537242.63305037DE
      156-14.548-93.376123234915.5815.581.0021036935.63377287DE
      260-3.368-76.54545454554.421.751.0021482408.44789973DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CGTXCognition Therapeutics Inc
      $ 3.57
      (50.63%)
      		4.01M
      RNAZTransCode Therapeutics Inc
      $ 0.355
      (20.09%)
      		5.82M
      NAMSNewAmsterdam Pharma Company NV
      $ 22.13
      (17.34%)
      		16.46k
      TCTuanChe Ltd
      $ 1.93
      (16.97%)
      		640
      YIBOPlanet Image International Ltd
      $ 3.38
      (15.95%)
      		46.19k
      VTVTvTv Therapeutics Inc
      $ 12.0634
      (-43.10%)
      		25.21k
      TGLTreasure Global Inc
      $ 1.436
      (-22.38%)
      		46.69k
      LUXHLuxUrban Hotels Inc
      $ 0.1526
      (-20.10%)
      		1.18M
      CEROCERo Therapeutics Holdings Inc
      $ 0.21
      (-17.97%)
      		1.19M
      SLNASelina Hospitality PLC
      $ 0.0261
      (-13.00%)
      		15.8M
      SLNASelina Hospitality PLC
      $ 0.0261
      (-13.00%)
      		15.8M
      RNAZTransCode Therapeutics Inc
      $ 0.355
      (20.09%)
      		5.82M
      CGTXCognition Therapeutics Inc
      $ 3.57
      (50.63%)
      		4.01M
      TLTiShares 20 plus Year Treasury Bond
      $ 92.98
      (-0.01%)
      		3.9M
      NVDANVIDIA Corporation
      $ 113.03
      (-0.03%)
      		2.38M

      Discussion

      View Full Feed
      Chartmaster Chartmaster 3 minutes ago
      Hey Clay, good to hear from you, been a while, miss the chart video's, what's your thoughts on HIRU?
      HIRU
      DewDiligence DewDiligence 3 minutes ago
      Correction—3M's updated 2024 non-GAAP EPS guidance was an increase of $0.20 at the low end from $6.80 to $7.00. The high end of the guidance range, $7.30, is unchanged.
      vein vein 3 minutes ago
      I think we are buying polariton
      LWLG
      Mavlo77 Mavlo77 3 minutes ago
      Only good news is that a reverse split usually tanks the share price in the aftermath of the split. Investors hate R/S. Well, in this case we’re already at the floor so there isn’t too much damage that can be done price wise. Since they let the share price fall to .0001 I feel like a buy back would
      KATX
      noradio noradio 3 minutes ago
      I hear yah, my guess is the MM's have sold a substantial amount of naked shares here. They might have got spooked when they realized how large this merger might be, that's why this is the first OTC stock Clay has posted on since 2021. He said he got a tip and that's why he popped in here... please!
      HIRU
      tmcfo tmcfo 3 minutes ago
      The real question is , are all those cars in the parking lot owned by employees who work for movement or velocity..
      MVNT
      Fire_starter Fire_starter 3 minutes ago
      SOUND ALL ALARMS SOUND ALL ALARMS BREAKTHROUGH🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥
      RNAZ
      DewDiligence DewDiligence 4 minutes ago
      Correction—3M's updated 2024 non-GAAP EPS guidance was an increase of $0.20 at the low end from $6.80 to $7.00. The high end of the guidance range, $7.30, is unchanged.
      MMM
      ALDRADJKD123 ALDRADJKD123 4 minutes ago
      Kamala starts her campaign with lies,

      https://youtu.be/h7PlgqZjLNw?si=PyvPzwZopO_-hH1q
      2H2 2H2 5 minutes ago
      No. Blow off top is starting. 6100 SPX. BTC 100,000. Sept Oct Is the top, then all hell breaks loose. Cheers.
      SPY
      ElectricWanderer60 ElectricWanderer60 5 minutes ago
      I'm in shock. Like I don't even know what to think at this point
      QEDN
      EnchantedTitan62 EnchantedTitan62 5 minutes ago
      I just found what I believe could be a gem -ZK. Will do much d.d. over the weekend for a possible long term holding in my portfolio.
      ZK
      Nemesis18 Nemesis18 5 minutes ago
      I think that you've just highlighted how mentally trapped you are in this forum's Hive Mind, that when I'm literally telling you the truth right to your face, you don't or won't believe it !
      NWBO
      ElectricWanderer60 ElectricWanderer60 5 minutes ago
      Well, the live meet went just like you would have expected
      QEDN
      zeusgodmd zeusgodmd 6 minutes ago
      3i management and Mr. Harlow
      RNAZ
      poguemahone poguemahone 6 minutes ago
      Put another way, if you lose $25, but gain $3, are you not still down $22?

      Think about it and let me know if my math is wrong.
      AVXL
      RickNagra RickNagra 6 minutes ago
      Oh wow. News.
      GNCP
      Here Today Here Today 6 minutes ago
      What did they talk about?
      RNAZ
      martyDg martyDg 6 minutes ago
      Well, it's almost August. I like to be accurate with my estimates, but I've learned not to expect too much and to avoid being overly optimistic—unlike those folks who said it would be approved in March, April, May, June, or July. I think it will be around October, but it could be 2025. Who knows? Th
      NWBO
      ALDRADJKD123 ALDRADJKD123 7 minutes ago
      Just proof Democrats Lie,,

      https://youtu.be/Is8cLGkXltM?si=m8vKQjVIfLh7WK4m
      Viewmont Viewmont 7 minutes ago
      Latest tweet? https://x.com/TonnerOWInc/status/1808150431513575444
      TONR
      janice shell janice shell 7 minutes ago
      I remember when Matt started IHub........he said it should be FUN to be/post here.........somehow that's gone bye-bye over the years.

      Not at all. It's still LOTS of fun to post here.
      theorysuit theorysuit 7 minutes ago
      Cvm offering. When's nwbo offering?
      NWBO
      Doc logic Doc logic 7 minutes ago
      iclight,

      Again, make your unsubstantiated claim now about how Advent is just for Linda but when approval comes and shareholders benefit from initial ramp up then max trajectory with Flaskworks feel free to say you were wrong or hasta la vista bebe; ). Best wishes.
      NWBO

      Your Recent History

      EU
      AB
      Ab Science
      Delayed Upgrade Clock